Center-Authored Papers

Filters: Author is Tapscott, S J  [Clear All Filters]
Journal Article
Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD.  1989.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.. Proceedings of the National Academy of Sciences of the United States of America. 86(14):5434-8. Abstract
Sancho S, Mongini T, Tanji K, Tapscott SJ, Walker WF, Weintraub H, Miller AD, Miranda AF.  1993.  Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.. The New England journal of medicine. 329(13):915-20. Abstract
Tawil R, Shaw DW, van der Maarel SM, Tapscott SJ.  2013.  Clinical trial preparedness in facioscapulohumeral dystrophy: Outcome measures and patient access: 8-9 April 2013, Leiden, The Netherlands.. Neuromuscular disorders : NMD.
Wang Z, Halbert CL, Lee D, Butts T, Tapscott SJ, Storb R, Miller AD.  2014.  Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model.. Gene therapy. 21(4):363-70. Abstract
Tapscott SJ, Miller AD, Olson JM, Berger MS, Groudine M, Spence AM.  1994.  Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.. Proceedings of the National Academy of Sciences of the United States of America. 91(17):8185-9. Abstract
Yang ZJP, Broz KD, Noderer WL, Ferreira JP, Overton KW, Spencer SL, Meyer T, Tapscott SJ, Attardi LD, Wang CL.  2015.  p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress.. Cell death and differentiation. 22(4):560-73. Abstract